Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:34-41
Published online before print June 8, 2006, doi: 10.1161/01.RES.0000231292.66084.cd
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/1/34    most recent
01.RES.0000231292.66084.cdv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrante, A.
Right arrow Articles by Hii, C. S.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrante, A.
Right arrow Articles by Hii, C. S.T.
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Other Vascular biology
(Circulation Research. 2006;99:34.)
© 2006 American Heart Association, Inc.


Molecular Medicine

A Novel ß-Oxa Polyunsaturated Fatty Acid Downregulates the Activation of the I{kappa}B Kinase/Nuclear Factor {kappa}B Pathway, Inhibits Expression of Endothelial Cell Adhesion Molecules, and Depresses Inflammation

Antonio Ferrante, Brenton S. Robinson, Harmeet Singh, Hubertus P.A. Jersmann, Judith V. Ferrante, Zhi H. Huang, Neil A. Trout, Michael J. Pitt, Deborah A. Rathjen, Christopher J. Easton, Alf Poulos, Rolf H. Prager, Frank S. Lee, Charles S.T. Hii

From the Departments of Immunopathology (A.F., B.S.R., H.S., H.P.A.J., J.V.F., A.P., C.S.T.H.), Women’s and Children’s Hospital, University of Adelaide, South Australia; the Department of Paediatrics (A.F., H.P.A.J., C.S.T.H.), University of Adelaide, South Australia; Section of Endocrinology and Metabolism (Z.H.H.), Rush Presbyterian Hospital-St Luke’s Medical Center, Chicago, Ill; School of Pharmaceutical, Molecular and Biomedical Sciences (A.F.), University of South Australia; Department of Chemistry (N.A.T., R.H.P.), Flinders University, Bedford Park, South Australia; Therapeutic Goods and Administration (M.J.P.), Symonston, Australia; Bionomics (D.A.R.), Thebarton, South Australia; Research School of Chemistry (C.J.E.), Australian National University, Canberra, Australia; and Department of Pathology and Laboratory Medicine (F.S.L.), University of Pennsylvania School of Medicine, Philadelphia.

Correspondence to Prof A. Ferrante, Department of Immunopathology, Women’s and Children’s Hospital, Adelaide, SA 5006, Australia. E-mail antonio.ferrante{at}adelaide.edu.au

Several novel polyunsaturated fatty acids (PUFAs) that contain either an oxygen or sulfur atom in the ß-position were found to exhibit more selective antiinflammatory properties than their natural PUFA counterparts. One of these, ß-oxa-23:4n-6, unlike natural PUFAs, lacked ability to stimulate oxygen radical production in neutrophils but caused marked inhibition of agonist-induced upregulation of leukocyte adhesion to cultured human umbilical vein endothelial cells (HUVEC) and E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 expression. In addition, ß-oxa-23:4n-6 inhibited acute and chronic inflammatory responses in mice as well as the upregulation of adhesion molecule expression in arterial endothelium. This action of ß-oxa-23:4n-6 required a functional 12- but not 5-lipoxygenase or cyclooxygenases, consistent with its metabolism via the 12-lipoxygenase pathway. Whereas ß-oxa-23:4n-6 did not affect the activation of mitogen-activated protein kinases by tumor necrosis factor, activation of the I{kappa}B kinase/nuclear factor {kappa}B pathway was selectively inhibited. These novel PUFAs could form the basis for a potential new class of pharmaceuticals for treating inflammatory diseases, including atherosclerosis.


Key Words: Long chain fatty acids • endothelial cells • adhesion molecules • lipoxygenase • NF-{kappa}B




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
B. D. Lamon and D. P. Hajjar
Inflammation at the Molecular Interface of Atherogenesis: An Anthropological Journey
Am. J. Pathol., November 1, 2008; 173(5): 1253 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Marantos, V. Mukaro, J. Ferrante, C. Hii, and A. Ferrante
Inhibition of the Lipopolysaccharide-Induced Stimulation of the Members of the MAPK Family in Human Monocytes/Macrophages by 4-Hydroxynonenal, a Product of Oxidized Omega-6 Fatty Acids
Am. J. Pathol., October 1, 2008; 173(4): 1057 - 1066.
[Abstract] [Full Text] [PDF]